Chelsea Therapeutics (CHTP) volatility elevated at 192; FDA asks for more efficacy data

Chelsea Therapeutics (Nasdaq: CHTP) is recently down $1.05 to $2.62 in the premarket on the FDA failing to approve Northera. Overall option implied volatility of 192 is above its 26-week average of 123 according to Track Data.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
• Marriott Vacations Worldwide (VAC) call put ratio 12 calls with a focus on October 105 and 110 calls
• Broadcom (AVGO) spreader of September 220 and 360 puts